WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2022)
Top pharmaceutical stocks in 2022 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
VTRS
VIATRIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$10.84B$8.94-2.61%$4.73B14.19x1.58
RDY
DR REDDYS LABORATORIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$8.78B$52.75-2.39%$575.00M29.11x0.54
IRWD
IRONWOOD PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.56B$10.15-3.06%$237.95M9.40x0.83
PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$526.55M$13.00-2.99%$116.91M10.74x2.55
ACRX
ACELRX PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$30.79M$0.21-5.43%$49.20M0.72x0.69
CTLT
CATALENT INC
NYSE
Drug Manufacturers - Specialty & Generic
$14.16B$78.71-2.83%$1.11B27.62x1.19
PCRX
PACIRA BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.63B$57.451.57%$143.87M66.03x1.29
SLDB
SOLID BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$54.57M$0.48-0.82%-$84.07M-0.63x0.29
PRPH
PROPHASE LABS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$194.32M$12.140.25%$37.93M7.02x0.44
ASRT
ASSERTIO HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$111.77M$2.320.43%$68.26M4.14x1.51
AMYT
AMRYT PHARMA PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$451.16M$7.03-3.96%$74.42M23.43x1.24
OGI
ORGANIGRAM HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$332.53M$1.0617.13%-$568.46k-13.42x0.14
AMPH
AMPHASTAR PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.41B$28.861.80%$141.31M15.35x0.45
CALT
CALLIDITAS THERAPEUTICS AB
NASDAQ
Drug Manufacturers - Specialty & Generic
$469.01M$15.871.89%-$59.30M-7.27x1.02
ZTS
ZOETIS INC
NYSE
Drug Manufacturers - Specialty & Generic
$71.43B$152.59-1.29%$3.24B34.52x2.01
ACB
AURORA CANNABIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$396.04M$1.337.26%-$1.18B-0.22x0.64
CRON
CRONOS GROUP INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.27B$3.3613.51%-$101.86M-11.59x0.04
ORGO
ORGANOGENESIS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$433.24M$3.31-0.30%$66.11M5.81x0.79
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$1.11B$29.52-5.87%$126.37M12.20x0.24
GHSI
GUARDION HEALTH SCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$11.15M$0.1831.16%-$20.53M-0.22x0.06
SNDL
SNDL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$664.00M$2.7923.45%-$86.57M-5.54x0.20
DRRX
DURECT CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$125.73M$0.55-0.72%-$36.86M-3.25x0.91
BFRI
BIOFRONTERA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$26.61M$1.131.80%-$24.99M-0.36x2.11
SBFM
SUNSHINE BIOPHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$15.11M$0.80-1.60%-$5.04M-0.16x0.00
TKNO
ALPHA TEKNOVA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$108.71M$3.87-0.51%-$17.91M-6.05x0.37
EGRX
EAGLE PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$343.01M$25.82-1.90%$47.71M14.11x0.60
OPTN
OPTINOSE INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$308.13M$3.703.35%-$60.65M-3.49x-3.02
EOLS
EVOLUS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$502.05M$8.951.13%-$69.59M-6.30x3.50
PLXP
PLX PHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$15.92M$0.570.00%-$40.53M-0.42x0.73
ZYNE
ZYNERBA PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$37.75M$0.8313.01%-$37.50M-0.89x0.17
HUGE
FSD PHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$34.64M$0.903.69%-$14.00M-2.11x0.20
EBS
EMERGENT BIOSOLUTIONS INC
NYSE
Drug Manufacturers - Specialty & Generic
$1.03B$20.68-0.77%$306.10M11.95x0.81
CGC
CANOPY GROWTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.80B$3.7522.15%-$2.07B-0.69x1.12
TLRY
TILRAY BRANDS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.09B$3.9030.87%-$300.81M-4.33x0.23
EVOK
EVOKE PHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.02M$2.102.94%-$7.55M-0.70x1.00
SCYX
SCYNEXIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$82.61M$2.53-0.78%-$48.51M-1.57x1.98
ZOM
ZOMEDICA CORP
NYSEMKT
Drug Manufacturers - Specialty & Generic
$205.79M$0.210.96%-$21.52M-11.05x0.04
DERM
JOURNEY MEDICAL CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$40.52M$2.30-3.64%-$27.87M-0.65x2.26
INCR
INTERCURE LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$218.00M$4.833.43%$17.74M24.90x0.51
VERU
VERU INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$914.47M$11.41-4.04%-$42.28M-19.02x0.37
FLGC
FLORA GROWTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$60.02M$0.7816.42%-$46.59M-1.01x0.27
SUPN
SUPERNUS PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.82B$34.070.95%$134.97M31.26x1.01
PRFX
PAINREFORM LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$6.59M$0.621.31%-$7.02M-0.91x0.05
JUPW
JUPITER WELLNESS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$16.52M$0.7711.30%-$24.11M-0.57x0.35
ANIP
ANI PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$583.96M$33.491.98%-$8.72M-7.53x1.33
AGRX
AGILE THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$11.75M$0.30-0.33%-$62.79M-0.01x8.60
NLTX
NEOLEUKIN THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$28.19M$0.66-2.65%-$59.05M-0.60x0.17
AERI
AERIE PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$748.30M$15.160.26%-$21.71M-14.58x-3.73
SISI
SHINECO INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$14.20M$0.873.10%-$25.48M-0.30x0.91
BHC
BAUSCH HEALTH COMPANIES INC
NYSE
Drug Manufacturers - Specialty & Generic
$2.67B$7.39-2.51%$2.92B56.85x-40.29
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.90M$1.74-7.94%-$54.03M-0.14x1.02
ADMP
ADAMIS PHARMACEUTICALS CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$20.70M$0.14-4.17%-$39.06M-0.51x1.51
SNOA
SONOMA PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.04M$2.27-1.30%-$5.06M-1.33x1.16
HEXO
HEXO CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$81.81M$0.2116.94%-$687.42M-0.09x1.09
CRDL
CARDIOL THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$57.36M$0.931.98%-$24.34M-2.17x0.18
CLVR
CLEVER LEAVES HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$35.27M$0.8236.67%-$27.28M-0.55x0.25
RDHL
REDHILL BIOPHARMA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$35.02M$0.61-1.92%-$58.25M-0.32x-32.86
HROW
HARROW HEALTH INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$322.40M$11.913.57%-$14.01M-13.23x16.12
ALVO
ALVOTECH
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.52B$6.790.00%-$159.65M-0.51x-3.62
THTX
THERATECHNOLOGIES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$197.85M$2.08-0.48%-$28.28M-5.10x-9.19
TAK
TAKEDA PHARMACEUTICAL CO LTD
NYSE
Drug Manufacturers - Specialty & Generic
$43.72B$13.12-2.45%$7.39B27.74x1.23
PRGO
PERRIGO CO PLC
NYSE
Drug Manufacturers - Specialty & Generic
$5.19B$38.58-0.64%$684.10M-44.34x1.25
SCTL
SOCIETAL CDMO INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$86.12M$1.52-2.56%$8.75M-6.08x3.11
RLMD
RELMADA THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.08B$35.844.19%-$156.67M-5.14x0.10
CYTH
CYCLO THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$17.55M$2.08-2.35%-$12.86M-1.24x0.22
COSM
COSMOS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$4.73M$0.18-4.71%-$151.78k-0.10x7.74
KMDA
KAMADA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$185.02M$4.13-9.83%-$1.30M-15.88x0.77
RMTI
ROCKWELL MEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.77M$1.29-3.37%-$23.85M-0.39x1.94
PETQ
PETIQ INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$229.72M$7.779.28%$51.61M-15.54x2.22
COLL
COLLEGIUM PHARMACEUTICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$575.03M$16.85-0.88%-$16.19M-16.85x5.30
VLNS
VALENS COMPANY INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$71.13M$0.8924.06%N/A-0.38x0.93
TXMD
THERAPEUTICSMD INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$62.30M$6.61-0.90%$18.38M-1.97x-6.61
MDVL
MEDAVAIL HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$76.02M$0.958.45%-$44.80M-0.74x0.61
CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$37.97M$2.594.86%-$1.86M-5.08x1.35
UPXI
UPEXI INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$67.35M$4.035.50%$329.51k-31.00x0.69
SXTC
CHINA SXT PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.66M$0.820.25%-$5.05M-0.15x1.04
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$42.54M$1.195.97%$2.13M59.50x0.41
HAPP
HAPPINESS DEVELOPMENT GROUP LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.53M$0.175.56%-$50.64M-0.14x0.26
PTPI
PETROS PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$9.93M$0.480.00%-$4.84M-0.47x0.49
IXHL
INCANNEX HEALTHCARE LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$116.57M$4.510.89%-$14.90M-7.22x0.06
AKAN
AKANDA CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$11.85M$0.411.23%-$6.73M-0.82x-4.66
YCBD
CBDMD INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$16.96M$0.2814.29%-$65.46M-0.22x0.23
AVDL
AVADEL PHARMACEUTICALS PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$386.27M$6.4612.74%-$105.24M-2.83x-48.40
XXII
22ND CENTURY GROUP INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$208.56M$0.970.10%-$41.73M-3.73x0.20
ELAN
ELANCO ANIMAL HEALTH INC
NYSE
Drug Manufacturers - Specialty & Generic
$6.00B$12.65-0.78%$727.00M-36.14x1.19
ATNX
ATHENEX INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$30.89M$0.25-5.22%-$167.07M-0.14x19.05
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$9.62B$8.66-2.04%$393.00M-9.12x4.00
LCI
LANNETT CO INC
NYSE
Drug Manufacturers - Specialty & Generic
$20.71M$0.480.42%-$141.68M-0.08x-2.93
ALIM
ALIMERA SCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$42.81M$6.126.81%-$9.41M-2.43x-4.86
PROC
PROCAPS GROUP SA
NASDAQ
Drug Manufacturers - Specialty & Generic
$778.37M$6.901.80%$9.37MN/A-17.45
EMBC
EMBECTA CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.68B$28.98-1.53%N/AN/A-2.24
TCDA
TRICIDA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$668.03M$12.005.26%-$135.46M-4.43x-2.03
CPHI
CHINA PHARMA HOLDINGS INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$7.26M$0.140.00%-$8.52k-1.80x3.45
AMRX
AMNEAL PHARMACEUTICALS INC
NYSE
Drug Manufacturers - Specialty & Generic
$673.83M$2.22-0.45%$254.70M-2.52x13.80
BGXX
BRIGHT GREEN CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$158.22M$0.991.33%N/AN/A0.66
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$396.96M$31.400.00%-$1.32M-241.54x-1.09

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Oct 2022?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the top pharmaceutical stock with a Zen Score of 61, which is 32 points higher than the pharmaceutical industry average of 29. It passed 21 out of 38 due diligence checks and has strong fundamentals. Viatris has seen its stock lose -33.48% over the past year, overperforming other pharmaceutical stocks by 3 percentage points.

Viatris has an average 1 year price target of $11.80, an upside of 31.99% from Viatris's current stock price of $8.94.

Viatris stock has a consensus Sell recommendation according to Wall Street analysts. Of the 6 analysts covering Viatris, 0% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second best pharmaceutical stock with a Zen Score of 58, which is 29 points higher than the pharmaceutical industry average of 29. It passed 18 out of 33 due diligence checks and has strong fundamentals. Ironwood Pharmaceuticals has seen its stock lose -24.93% over the past year, overperforming other pharmaceutical stocks by 12 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $14.33, an upside of 41.21% from Ironwood Pharmaceuticals's current stock price of $10.15.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Ironwood Pharmaceuticals, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Dr Reddys Laboratories (NYSE:RDY)


Dr Reddys Laboratories (NYSE:RDY) is the third best pharmaceutical stock with a Zen Score of 58, which is 29 points higher than the pharmaceutical industry average of 29. It passed 22 out of 38 due diligence checks and has strong fundamentals. Dr Reddys Laboratories has seen its stock lose -19.91% over the past year, overperforming other pharmaceutical stocks by 17 percentage points.

Dr Reddys Laboratories has an average 1 year price target of $69.00, an upside of 30.81% from Dr Reddys Laboratories's current stock price of $52.75.

Dr Reddys Laboratories stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Dr Reddys Laboratories, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 7 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) has an annual dividend yield of 5.26%, which is 3 percentage points higher than the pharmaceutical industry average of 2.41%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of 73% indicates that its high dividend yield is sustainable for the long-term.

2. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.69%, which is 1 percentage points higher than the pharmaceutical industry average of 2.41%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 39.7% indicates that its dividend yield is sustainable for the long-term.

3. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 2.64%, which is the same as the pharmaceutical industry average of 2.41%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -114.9% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -0.08% in the last day, and up 3.07% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 86, which is 56 points higher than the pharmaceutical industry average of 30. It passed 6 out of 7 valuation due diligence checks.

Viatris's stock has dropped -33.48% in the past year. It has overperformed other stocks in the pharmaceutical industry by 3 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Ironwood Pharmaceuticals has a valuation score of 86, which is 56 points higher than the pharmaceutical industry average of 30. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has dropped -24.93% in the past year. It has overperformed other stocks in the pharmaceutical industry by 12 percentage points.

3. Acelrx Pharmaceuticals (NASDAQ:ACRX)


Acelrx Pharmaceuticals (NASDAQ:ACRX) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Acelrx Pharmaceuticals has a valuation score of 71, which is 41 points higher than the pharmaceutical industry average of 30. It passed 5 out of 7 valuation due diligence checks.

Acelrx Pharmaceuticals's stock has dropped -79.51% in the past year. It has underperformed other stocks in the pharmaceutical industry by -43 percentage points.

Are pharmaceutical stocks a good buy now?

43.75% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 76.77% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 20.51x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.